Pharmaceutical

Nxera Pharma and Antiverse to design antibodies targeting GPCRs

Nxera Pharma has entered a collaboration and licensing agreement with Antiverse to design antibodies for GPCRs.

Nov 7, 2024 - 06:00
Nxera Pharma and Antiverse to design antibodies targeting GPCRs
Nxera Pharma has entered a collaboration and licensing agreement with Antiverse to design antibodies for GPCRs.
Read the original article

Tags:

Previous Article

Trump triumphs but impact on healthcare industry remains unclear

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Phase I/II trial begins for SpyGlass intraocular drug delivery implant

Phase I/II trial begins for SpyGlass intraocular drug d...

Oct 31, 2023

A psychologist’s lifetime of challenging assumptions while living with paralysis

A psychologist’s lifetime of challenging assumptions wh...

Jul 26, 2023

STAT+: Pharmalittle: Manufacturers say bird flu shots for humans can be made quickly; obesity guidelines for children disappoint

STAT+: Pharmalittle: Manufacturers say bird flu shots f...

Mar 20, 2023